68Ga/177Lu-PSMA theranostics in recurrent grade 3 and grade 4 glioma
Latest Information Update: 14 Mar 2023
At a glance
- Drugs Lu-177-PSMA-I and T (Primary) ; Lutetium-177 zadavotide guraxetan (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- Acronyms Glioma-Theranostics
Most Recent Events
- 14 Mar 2023 New trial record